4-hydroxytamoxifen
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for 4-hydroxytamoxifen, covering 2015-07-21 to 2024-12-18. Get the full timeline:
Most recent: Clinical Trial Update: Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast [Phase 2]